Weight-loss drug users actually eating more chocolate — not less, candy company says
Published on March 12, 2026.
Swiss chocolatier Lindt & Spruengli has reported that chocolate sales are increasing faster among U.S. users of GLP-1 weight-loss drugs than the rest of the population. This contradicts predictions that the drugs would reduce confectionery demand. An internal study found that 15% of U.,S. households use GLP1s, representing 17.5% of chocolate sales. The company's CEO, Adalbert Lechner, stated that consumers are upgrading to premium products rather than high-calorie intake categories. He also predicted that GLP 1 pills will expand the use of the drugs to patients beyond the users of injectables, including more men and younger patients.
Related Articles
Exercise Physiologist Reveals the 1 Type of Workout He Never Skips to Age Better
Exercise Physicist Cedric X. Bryant recommends skipping strength training as a preventable form of aging, enhancing longevity, fitness, and metabolic health, despite health concerns.
Hawley rolls out bill to nix FDA approval for mifepristone, used for almost two-thirds of US abortions
Sen. Josh Hawley is seeking to block FDA approval for mifepristone, a keystone of US abortion practices, citing safety concerns and widespread abuse.
FDA Issues ‘Serious Violations’ Warning to Ozempic Maker Over Unreported Deaths
The FDA issued a warning to Novo Nordisk over inadequate reporting of multiple deaths from its flagship product, Ozempic.